Cellectar Biosciences, Inc. — Director's Dealing 2014

Aug 22, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2014-08-20

Reporting Person: Pedder Simon (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-20	Common Stock, par value $0.00001 per share	P	13300	$3.75	Acquired	13300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-20	Stock purchase warrant (right to buy)	$4.68	P	13300	Acquired	2019-08-20	Common Stock (13300)	Direct